We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
+15.52%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$996M
AUM Growth
-$1.91B
Cap. Flow
-$2.11B
Cap. Flow %
-211.83%
Top 10 Hldgs %
20.58%
Holding
239
New
10
Increased
21
Reduced
180
Closed
28

Sector Composition

Rank Sector Weight
1 Technology 30.35%
2 Healthcare 21%
3 Industrials 11.06%
4 Financials 10.57%
5 Consumer Discretionary 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPNC
76
DELISTED
Spectranetics Corp
SPNC
$4.71M 0.47%
161,808
-415,342
-72% -$11.1M
CGNX icon
77
Cognex
CGNX
$11.3B
$4.68M 0.47%
111,434
-49,220
-31% -$1.8M
OXFD
78
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$4.58M 0.46%
+295,477
New +$4.22M
GWR
79
DELISTED
Genesee & Wyoming Inc.
GWR
$4.56M 0.46%
67,142
-439,031
-87% -$31.7M
JRVR icon
80
James River Group Holdings
JRVR
$217M
$4.55M 0.46%
106,283
-320,867
-75% -$13.3M
ELLI
81
DELISTED
Ellie Mae Inc
ELLI
$4.48M 0.45%
44,688
+1,597
+4% +$147K
TER icon
82
Teradyne
TER
$59.3B
$4.41M 0.44%
141,802
-869,954
-86% -$24.9M
LAUR icon
83
Laureate Education
LAUR
$5.28B
$4.16M 0.42%
+291,250
New +$3.86M
NXST icon
84
Nexstar Media Group
NXST
$5.97B
$4.03M 0.4%
57,475
-153,425
-73% -$10.3M
MLNX
85
DELISTED
Mellanox Technologies, Ltd.
MLNX
$4.02M 0.4%
78,925
-457,420
-85% -$21.7M
FRPT icon
86
Freshpet
FRPT
$3.22B
$4.01M 0.4%
364,352
-91,580
-20% -$989K
TYPE
87
DELISTED
Monotype Imaging Holdings Inc.
TYPE
$3.98M 0.4%
197,892
-130,198
-40% -$2.72M
ACHC icon
88
Acadia Healthcare
ACHC
$2.94B
$3.94M 0.4%
90,479
-485,221
-84% -$19.7M
ZEN
89
DELISTED
ZENDESK INC
ZEN
$3.85M 0.39%
137,124
-149,876
-52% -$3.88M
QTS
90
DELISTED
QTS REALTY TRUST, INC.
QTS
$3.76M 0.38%
77,083
-352,892
-82% -$17.7M
KMT icon
91
Kennametal
KMT
$2.52B
$3.65M 0.37%
93,000
-339,373
-78% -$12.5M
RHT
92
DELISTED
Red Hat Inc
RHT
$3.59M 0.36%
41,536
-300,940
-88% -$23.9M
BIO icon
93
Bio-Rad Laboratories Class A
BIO
$9.42B
$3.58M 0.36%
17,964
-157,270
-90% -$30.3M
JBTM
94
JBT Marel
JBTM
$6.39B
$3.58M 0.36%
40,715
-76,927
-65% -$6.67M
CRCM
95
DELISTED
CARE.COM, INC.
CRCM
$3.42M 0.34%
273,150
-418,645
-61% -$4.15M
ENSG icon
96
The Ensign Group
ENSG
$10.7B
$3.36M 0.34%
191,041
-59,351
-24% -$1.07M
KNSL icon
97
Kinsale Capital Group
KNSL
$8.51B
$3.3M 0.33%
103,131
+14,741
+17% +$457K
HUBS icon
98
HubSpot
HUBS
$10.5B
$3.29M 0.33%
54,270
-67,509
-55% -$3.82M
NNBR icon
99
NN Inc
NNBR
$311M
$3.25M 0.33%
+128,907
New +$2.69M
LGND icon
100
Ligand Pharmaceuticals
LGND
$6.36B
$3.17M 0.32%
48,011
-472,964
-91% -$31.1M

Similar funds

Granahan Investment Management's Q1 2017 Portfolio in Review

As of Q1 2017, Granahan Investment Management held 239 positions worth $996M, down 66% from $2.91B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Granahan Investment Management withdrew a net $2.11B in Q1 2017, closing 28 positions and reducing 180 holdings. Its most notable exit was Cynosure, Inc. Class A, an estimated $31.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 33% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Granahan Investment Management opened a new position in Paylocity worth $4.94M.

  • Granahan Investment Management's largest Q1 2017 buy was Paylocity: 127,782 shares worth $4.94M.
  • Granahan Investment Management added most to Kornit Digital in Q1 2017, an estimated $10.6M increase.
  • Granahan Investment Management's biggest Q1 2017 reduction was Abiomed Inc, cutting an estimated $52.4M.
  • Granahan Investment Management fully exited Cynosure, Inc. Class A in Q1 2017, selling an estimated $31.8M.
  • Granahan Investment Management's ten largest holdings make up 21% of its $996M portfolio in Q1 2017.
  • Granahan Investment Management opened 10 new positions and closed 28 in Q1 2017.
  • Granahan Investment Management's portfolio value fell 66% quarter-over-quarter to $996M.

Based on Granahan Investment Management's 13F filing for Q1 2017, filed 15 May 2017.